JGC
MDCO

J. Goldman & Co’s Medicines Co MDCO Stock Holding History

J. Goldman & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-88,400
Closed -$3.34M – 430
2016
Q3 		$3.34M Sell
88,400
-57,600
-39% -$2.17M 0.19% 147
2016
Q2 		$4.91M Buy
146,000
+28,600
+24% +$1.01M 0.26% 101
2016
Q1 		$3.73M Sell
117,400
-25,989
-18% -$849K 0.23% 117
2015
Q4 		$5.35M Buy
+143,389
New +$5.42M 0.55% 65
2015
Q3 		– Sell
-25,689
Closed -$735K – 331
2015
Q2 		$735K Buy
+25,689
New +$716K 0.04% 197
2014
Q2 		– Sell
-422,250
Closed -$12M – 332
2014
Q1 		$12M Buy
422,250
+392,250
+1,308% +$13M 0.88% 19
2013
Q4 		$1.16M Sell
30,000
-233,750
-89% -$8.36M 0.15% 151
2013
Q3 		$8.84M Buy
+263,750
New +$8.4M 0.83% 23

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

J. Goldman & Co's MDCO Position: Q4 2016 in Review

J. Goldman & Co sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 88,400 shares — an estimated $3.34M sold.

J. Goldman & Co first reported a position in MDCO in Q3 2013 and held it in 8 quarters. The position peaked at $12M in Q1 2014. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • J. Goldman & Co reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • J. Goldman & Co sold 88,400 Medicines Co shares in Q4 2016, an estimated $3.34M.
  • J. Goldman & Co first reported a position in Medicines Co in Q3 2013 and held it in 8 quarters.
  • J. Goldman & Co's Medicines Co position peaked at $12M in Q1 2014.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on J. Goldman & Co's 13F filing for Q4 2016, filed 13 Feb 2017.